Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Bait and Switch on Medicare Drug Price Controls

Posted on May 12, 2022May 12, 2022 by John C. Goodman

New Gingrich the WSJ:

All told, the Congressional Budget Office estimated that the Democrats’ (reconciliation) bill would have diverted $266 billion in Medicare spending to pay for other programs if passed into law. Taking a quarter of a trillion dollars out of an already-stressed Medicare program would be a disaster for seniors….

reforms championed by the Trump administration … would have required negotiated savings between PBMs and drugmakers to pass directly to seniors by accounting for the rebate when determining the cost-sharing amount. Currently, patients often end up paying costs based on the sticker price of medications rather than the price that has been negotiated between the manufacturers and PBMs.

1 thought on “Bait and Switch on Medicare Drug Price Controls”

  1. Devon Herrick says:
    May 12, 2022 at 12:57 pm

    The difference between list price and net (negotiated) price has been rising in health care. That is a problem because it becomes the basis for shenanigans between payer and provider. General Motors provides dealers a rebate based on end-of-year volume but it’s probably only a few percentage points, not two-thirds of list price.

    Loading...
    Reply

Join the conversation.Cancel reply

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom
%d